Answers are grounded in this paper and cite their sources.
Demonstrates cholesterol depletion disrupts LOX-1 function and promotes exosome release, indicating membrane-dependent regulation.
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), the primary receptor for ox-LDL in endothelial cells, is a multi-ligand scavenger receptor that plays a crucial role in the pathogenesis of atherosclerosis and cardiovascular disorders and recently identified as a tumor marker. LOX-1 is naturally present in caveolae/lipid rafts in plasma membranes and disruption of these membrane domains by cholesterol-lowering drugs leads to a spatial disorganization of LOX-1 and a marked loss of specific LOX-1 function in terms of ox-LDL binding and internalization. Moreover, cholesterol depletion triggers the release of LOX-1 in exosomes and enhances shedding of LOX-1 ectodomain.
No takes yet. Share an insight, caveat, or question.
Raniolo et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: